おはなし掲示板

トップページへ

piZCgTCcfNroKjcp

日時: 2018/10/02 19:54
名前: Adam
URL: http://qual-proliant.co.uk/stmap_1e6b0.html?dilantin.cialis.quetiapine.persantine
ID: PZIExOn.

Some First Class stamps https://www.electricguitardigest.com/stmap_f98c0.html?tizanidine.chloramphenicol.levitra.trental medair.org LEVERKUSEN (Alliance News) - German pharmaceutical giant Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) Tuesday said it plans to accelerate the development of five promising drug candidates that are currently undergoing phase I and II clinical studies. The goal is to progress these experimental drugs - in the areas of oncology, cardiology and women's health - into phase III clinical studies by 2015.

Page:[1]

タイトル   このスレッドを先頭に移動
名前
E-Mail
URL
パスワード (返信内容の修正や削除時に使用)
コメント
画像ファイル
     名前、E-Mail、URL、パスワードを保存する